Sign in

CIK 0000879407

  • Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
Operating
EIN
460408024
Phone
+1 626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 48 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-06-09 McKenney Charles Director Option exercise · Stock Option (right to buy) −10,000 53,000
2014-02-12 Myszkowski Kenneth Allen CFO Option exercise +16,000 $2.01 $32K 87,500
2014-02-12 Myszkowski Kenneth Allen CFO Sale −16,000 $18.77 $300K 71,500
2014-02-12 Myszkowski Kenneth Allen CFO Option exercise · Stock Option −16,000 312,000
2014-02-07 FRYKMAN EDWARD W Director Option exercise +5,000 $10.00 $50K 27,000
2014-02-07 FRYKMAN EDWARD W Director Sale −3,148 $15.98 $50K 23,852
2014-02-07 FRYKMAN EDWARD W Director Option exercise · Stock Option −5,000 77,500
2014-02-06 FRYKMAN EDWARD W Director Grant or award +15,000 22,000
2014-02-06 McKenney Charles Director Grant or award +15,000 17,220
2014-02-06 PERRY MICHAEL S Director Grant or award +15,000 15,000
2014-02-06 GIVEN DOUGLAS B Director Grant or award +20,000 20,000
2014-02-06 GIVEN BRUCE D Chief Operating Officer Grant or award +125,000 125,000
2014-02-06 GIVEN BRUCE D Chief Operating Officer Grant or award · Stock Options +50,000 436,000
2014-02-06 Anzalone Christopher Richard President and CEO Grant or award +210,000 244,173
2014-02-06 Anzalone Christopher Richard President and CEO Grant or award · Stock Options +60,000 786,466
2014-02-06 Lewis David L. Chief Scientific Officer Grant or award · Stock Options +120,000 317,500
2014-02-06 Myszkowski Kenneth Allen CFO Grant or award +70,000 71,500
2014-02-06 Myszkowski Kenneth Allen CFO Grant or award · Stock Options +50,000 328,000
2014-01-02 Lewis David L. Chief Scientific Officer Option exercise +10,000 $4.60 $46K 10,000
2014-01-02 Lewis David L. Chief Scientific Officer Option exercise +2,500 $5.19 $13K 12,500

Page 40 of 46 · 902 trades